nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0843	0.611	CbGbCtD
Cevimeline—Joint dislocation—Cyclosporine—focal segmental glomerulosclerosis	0.0537	0.0623	CcSEcCtD
Cevimeline—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0536	0.389	CbGbCtD
Cevimeline—Gingival hyperplasia—Cyclosporine—focal segmental glomerulosclerosis	0.0188	0.0218	CcSEcCtD
Cevimeline—Salivary gland enlargement—Cyclosporine—focal segmental glomerulosclerosis	0.0182	0.0212	CcSEcCtD
Cevimeline—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.0177	0.0206	CcSEcCtD
Cevimeline—Toxicity to various agents—Cyclosporine—focal segmental glomerulosclerosis	0.0177	0.0206	CcSEcCtD
Cevimeline—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0168	0.0195	CcSEcCtD
Cevimeline—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0145	0.0168	CcSEcCtD
Cevimeline—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0165	CcSEcCtD
Cevimeline—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0161	CcSEcCtD
Cevimeline—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.0133	0.0155	CcSEcCtD
Cevimeline—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0149	CcSEcCtD
Cevimeline—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.0127	CcSEcCtD
Cevimeline—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0125	CcSEcCtD
Cevimeline—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0125	CcSEcCtD
Cevimeline—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0123	CcSEcCtD
Cevimeline—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0122	CcSEcCtD
Cevimeline—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0122	CcSEcCtD
Cevimeline—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00915	0.0106	CcSEcCtD
Cevimeline—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00882	0.0102	CcSEcCtD
Cevimeline—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00872	0.0101	CcSEcCtD
Cevimeline—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00862	0.00999	CcSEcCtD
Cevimeline—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00833	0.00966	CcSEcCtD
Cevimeline—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00781	0.00906	CcSEcCtD
Cevimeline—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00781	0.00906	CcSEcCtD
Cevimeline—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00773	0.00897	CcSEcCtD
Cevimeline—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00758	0.00879	CcSEcCtD
Cevimeline—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00743	0.00862	CcSEcCtD
Cevimeline—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00709	0.00823	CcSEcCtD
Cevimeline—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00703	0.00815	CcSEcCtD
Cevimeline—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00697	0.00808	CcSEcCtD
Cevimeline—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00673	0.0078	CcSEcCtD
Cevimeline—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00656	0.00761	CcSEcCtD
Cevimeline—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00651	0.00755	CcSEcCtD
Cevimeline—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.00749	CcSEcCtD
Cevimeline—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.00749	CcSEcCtD
Cevimeline—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.0064	0.00743	CcSEcCtD
Cevimeline—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0062	0.0072	CcSEcCtD
Cevimeline—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00581	0.00673	CcSEcCtD
Cevimeline—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00577	0.00669	CcSEcCtD
Cevimeline—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00577	0.00669	CcSEcCtD
Cevimeline—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00561	0.00651	CcSEcCtD
Cevimeline—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00557	0.00646	CcSEcCtD
Cevimeline—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00557	0.00646	CcSEcCtD
Cevimeline—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00557	0.00646	CcSEcCtD
Cevimeline—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.00638	CcSEcCtD
Cevimeline—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.00638	CcSEcCtD
Cevimeline—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00546	0.00633	CcSEcCtD
Cevimeline—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00546	0.00633	CcSEcCtD
Cevimeline—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00543	0.00629	CcSEcCtD
Cevimeline—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00532	0.00617	CcSEcCtD
Cevimeline—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00532	0.00617	CcSEcCtD
Cevimeline—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.00598	CcSEcCtD
Cevimeline—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.00588	CcSEcCtD
Cevimeline—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00498	0.00577	CcSEcCtD
Cevimeline—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00498	0.00577	CcSEcCtD
Cevimeline—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00571	CcSEcCtD
Cevimeline—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.00567	CcSEcCtD
Cevimeline—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.00567	CcSEcCtD
Cevimeline—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00561	CcSEcCtD
Cevimeline—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00478	0.00555	CcSEcCtD
Cevimeline—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.00552	CcSEcCtD
Cevimeline—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.0054	CcSEcCtD
Cevimeline—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.00537	CcSEcCtD
Cevimeline—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.00537	CcSEcCtD
Cevimeline—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.00531	CcSEcCtD
Cevimeline—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.00531	CcSEcCtD
Cevimeline—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00442	0.00512	CcSEcCtD
Cevimeline—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.0051	CcSEcCtD
Cevimeline—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.0051	CcSEcCtD
Cevimeline—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.005	CcSEcCtD
Cevimeline—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00423	0.0049	CcSEcCtD
Cevimeline—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00419	0.00486	CcSEcCtD
Cevimeline—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.00481	CcSEcCtD
Cevimeline—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00411	0.00477	CcSEcCtD
Cevimeline—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00411	0.00477	CcSEcCtD
Cevimeline—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00409	0.00475	CcSEcCtD
Cevimeline—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.00472	CcSEcCtD
Cevimeline—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.004	0.00464	CcSEcCtD
Cevimeline—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00393	0.00456	CcSEcCtD
Cevimeline—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00454	CcSEcCtD
Cevimeline—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0039	0.00452	CcSEcCtD
Cevimeline—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.00448	CcSEcCtD
Cevimeline—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.00446	CcSEcCtD
Cevimeline—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.00443	CcSEcCtD
Cevimeline—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00378	0.00439	CcSEcCtD
Cevimeline—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.00437	CcSEcCtD
Cevimeline—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.00427	CcSEcCtD
Cevimeline—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00362	0.0042	CcSEcCtD
Cevimeline—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00362	0.0042	CcSEcCtD
Cevimeline—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00404	CcSEcCtD
Cevimeline—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00391	CcSEcCtD
Cevimeline—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.00377	CcSEcCtD
Cevimeline—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00376	CcSEcCtD
Cevimeline—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00371	CcSEcCtD
Cevimeline—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.00369	CcSEcCtD
Cevimeline—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.00363	CcSEcCtD
Cevimeline—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00359	CcSEcCtD
Cevimeline—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00355	CcSEcCtD
Cevimeline—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00345	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00343	CcSEcCtD
Cevimeline—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.00341	CcSEcCtD
Cevimeline—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00335	CcSEcCtD
Cevimeline—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00334	CcSEcCtD
Cevimeline—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00333	CcSEcCtD
Cevimeline—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00331	CcSEcCtD
Cevimeline—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00328	CcSEcCtD
Cevimeline—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.00324	CcSEcCtD
Cevimeline—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00322	CcSEcCtD
Cevimeline—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00322	CcSEcCtD
Cevimeline—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.0032	CcSEcCtD
Cevimeline—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00319	CcSEcCtD
Cevimeline—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00319	CcSEcCtD
Cevimeline—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.00313	CcSEcCtD
Cevimeline—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.0031	CcSEcCtD
Cevimeline—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.00308	CcSEcCtD
Cevimeline—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.00297	CcSEcCtD
Cevimeline—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00296	CcSEcCtD
Cevimeline—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00295	CcSEcCtD
Cevimeline—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00294	CcSEcCtD
Cevimeline—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00293	CcSEcCtD
Cevimeline—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00289	CcSEcCtD
Cevimeline—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00284	CcSEcCtD
Cevimeline—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.00275	CcSEcCtD
Cevimeline—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00274	CcSEcCtD
Cevimeline—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00268	CcSEcCtD
Cevimeline—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00265	CcSEcCtD
Cevimeline—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00264	CcSEcCtD
Cevimeline—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00261	CcSEcCtD
Cevimeline—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00257	CcSEcCtD
Cevimeline—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00253	CcSEcCtD
Cevimeline—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00252	CcSEcCtD
Cevimeline—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00247	CcSEcCtD
Cevimeline—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00241	CcSEcCtD
Cevimeline—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00238	CcSEcCtD
Cevimeline—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00237	CcSEcCtD
Cevimeline—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00236	CcSEcCtD
Cevimeline—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00232	CcSEcCtD
Cevimeline—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00231	CcSEcCtD
Cevimeline—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.0023	CcSEcCtD
Cevimeline—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00224	CcSEcCtD
Cevimeline—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00223	CcSEcCtD
Cevimeline—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00222	CcSEcCtD
Cevimeline—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00219	CcSEcCtD
Cevimeline—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00219	CcSEcCtD
Cevimeline—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00219	CcSEcCtD
Cevimeline—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00218	CcSEcCtD
Cevimeline—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00216	CcSEcCtD
Cevimeline—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00211	CcSEcCtD
Cevimeline—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.0021	CcSEcCtD
Cevimeline—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00208	CcSEcCtD
Cevimeline—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00206	CcSEcCtD
Cevimeline—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00205	CcSEcCtD
Cevimeline—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00204	CcSEcCtD
Cevimeline—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00203	CcSEcCtD
Cevimeline—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.002	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00191	CcSEcCtD
Cevimeline—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0019	CcSEcCtD
Cevimeline—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00188	CcSEcCtD
Cevimeline—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00187	CcSEcCtD
Cevimeline—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00186	CcSEcCtD
Cevimeline—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00185	CcSEcCtD
Cevimeline—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00182	CcSEcCtD
Cevimeline—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00181	CcSEcCtD
Cevimeline—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00179	CcSEcCtD
Cevimeline—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00179	CcSEcCtD
Cevimeline—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00173	CcSEcCtD
Cevimeline—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00171	CcSEcCtD
Cevimeline—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00167	CcSEcCtD
Cevimeline—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00166	CcSEcCtD
Cevimeline—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00166	CcSEcCtD
Cevimeline—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00154	CcSEcCtD
Cevimeline—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.0015	CcSEcCtD
Cevimeline—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00148	CcSEcCtD
Cevimeline—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00143	CcSEcCtD
Cevimeline—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00139	CcSEcCtD
Cevimeline—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00133	CcSEcCtD
Cevimeline—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00132	CcSEcCtD
Cevimeline—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00132	CcSEcCtD
Cevimeline—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00131	CcSEcCtD
Cevimeline—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00125	CcSEcCtD
